A microscopic landscape of the invasive breast cancer genome

Ping Zheng, Yuchao Xia, Tiansheng Shen, Vishwas Parekh, Gene P. Siegal, Isam‐Eldin Eltoum, Jianbo He, Dongquan Chen, Minghua Deng, Ruibin Xi, Dejun ShenScientific 2016 · DOI

Abstract

Histologic grade is one of the most important microscopic features used to predict the prognosis of invasive breast cancer and may serve as a marker for studying cancer driving genomic abnormalities in vivo. We analyzed whole genome sequencing data from 680 cases of TCGA invasive ductal carcinomas of the breast and correlated them to corresponding pathology information. Ten genetic abnormalities were found to be statistically associated with histologic grade, including three most prevalent cancer driver events, TP53 and PIK3CA mutations and MYC amplification. A distinct genetic interaction among these genomic abnormalities was revealed as measured by the histologic grading score. While TP53 mutation and MYC amplification were synergistic in promoting tumor progression, PIK3CA mutation was found to have alleviated the oncogenic effect of either the TP53 mutation or MYC amplification, and was associated with a significant reduction in mitotic activity in TP53 mutated and/or MYC amplified breast cancer. Furthermore, we discovered that different types of genetic abnormalities (mutation versus amplification) within the same cancer driver gene (PIK3CA or GATA3) were associated with opposite histologic changes in invasive breast cancer. In conclusion, our study suggests that histologic grade may serve as a biomarker to define cancer driving genetic events in vivo.

Introduction

In the era of precision medicine, the abundance of genomic data often outpaces our understanding of how these mutations manifest in a living patient (in vivo). While in vitro experiments provide insights into single-gene functions, they frequently fail to capture the complex "conversations" between multiple mutations within the human body. This study addresses this gap by utilizing histologic grade—a standard clinical measure of tumor aggressiveness—as a phenotypic lens to decode the relationship between physical tumor features and specific genetic abnormalities.

Methodology

The study involved a retrospective analysis of 680 cases of Invasive Ductal Carcinoma (IDC) sourced from The Cancer Genome Atlas (TCGA). The cohort was selected based on the availability of high-quality whole-genome sequencing data and complete pathology reports.

  • Genomic Analysis: Researchers identified significantly mutated genes and copy number alterations using MutSig and GISTIC2 algorithms.
  • Pathological Correlation: Genetic events were mapped to the Nottingham histologic grade, which evaluates tumors based on three key microscopic features: tubule formation, nuclear pleomorphism, and mitotic count.
Histological characteristics of invasive ductal carcinoma across grades 1-3.

Genomic Drivers and Histologic Grade

Out of thousands of identified mutations, only ten genetic abnormalities were significantly associated with histologic grade. This finding aligns with the "Mountains and Hills" theory of cancer genomics, suggesting that a small number of major "mountain" drivers dictate tumor behavior, while numerous "passenger" mutations have minimal impact.

Hierarchical clustering of ten candidate driver genes across histologic grades G1, G2, and G3.

The most prevalent drivers identified were TP53 mutations (37%), PIK3CA mutations (31%), and MYC amplifications (27%). TP53 mutations and MYC amplifications were strongly linked to high-grade (Grade 3) tumors, whereas PIK3CA mutations were significantly more common in low-grade (Grade 1) tumors.

Genetic Interactions and Phenotypic Impact

A key discovery of this research is the complex interaction between different genomic drivers. While TP53 mutations and MYC amplifications act synergistically to promote tumor progression and higher grades, PIK3CA mutations appear to exert an antagonistic effect. In tumors harboring both TP53/MYC and PIK3CA mutations, the latter was associated with a significant reduction in mitotic activity (p < 0.05), effectively acting as a functional brake on the rapid proliferation typically driven by TP53.

Furthermore, the type of genetic abnormality significantly influences the phenotype. For genes such as PIK3CA and GATA3, a mutation was associated with a lower, less aggressive grade, while an amplification (extra gene copies) correlated with a higher, more aggressive grade.

Conclusion

The study demonstrates that hierarchical clustering of just ten candidate driver genes is sufficient to distinguish high-grade IDCs from lower-grade ones. These findings suggest that histologic grade can serve as a reliable biomarker for identifying cancer-driving genetic events in vivo. From a clinical perspective, low-grade tumors driven primarily by PIK3CA mutations may be ideal candidates for targeted therapies, whereas high-grade tumors with multiple interacting drivers likely require more complex combinatorial treatment strategies.

Summary updated

Abstract

Histologic grade is one of the most important microscopic features used to predict the prognosis of invasive breast cancer and may serve as a marker for studying cancer driving genomic abnormalities in vivo. We analyzed whole genome sequencing data from 680 cases of TCGA invasive ductal carcinomas of the breast and correlated them to corresponding pathology information. Ten genetic abnormalities were found to be statistically associated with histologic grade, including three most prevalent cancer driver events, TP53 and PIK3CA mutations and MYC amplification. A distinct genetic interaction among these genomic abnormalities was revealed as measured by the histologic grading score. While TP53 mutation and MYC amplification were synergistic in promoting tumor progression, PIK3CA mutation was found to have alleviated the oncogenic effect of either the TP53 mutation or MYC amplification, and was associated with a significant reduction in mitotic activity in TP53 mutated and/or MYC amplified breast cancer. Furthermore, we discovered that different types of genetic abnormalities (mutation versus amplification) within the same cancer driver gene (PIK3CA or GATA3) were associated with opposite histologic changes in invasive breast cancer. In conclusion, our study suggests that histologic grade may serve as a biomarker to define cancer driving genetic events in vivo.
BibTeX
@inproceedings{zheng2016microscopic,
  author = {Ping Zheng and Yuchao Xia and Tiansheng Shen and Vishwas Parekh and Gene P. Siegal and Isam‐Eldin Eltoum and Jianbo He and Dongquan Chen and Minghua Deng and Ruibin Xi and Dejun Shen},
  title = {{A microscopic landscape of the invasive breast cancer genome}},
  booktitle = {Scientific},
  year = {2016},
  doi = {10.1038/srep27545},
}
Figure